In one paragraphArticle in American journal of physiology. Endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Stacey HembruffThe University of Kansas Cancer Center, Kansas City, KS, United States.
Alexander DekonenkoThe University of Kansas Cancer Center, Kansas City, KS, United States.
Mihaela E SardiuThe University of Kansas Cancer Center, Kansas City, KS, United States.
Samuel G MackintoshNational Resource for Quantitative Proteomics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States.
Stephanie D ByrumNational Resource for Quantitative Proteomics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States.
Roy A JensenThe University of Kansas Cancer Center, Kansas City, KS, United States.
Funding
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1MSupplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4Mlongitudinal assessment of stress and stress-related concepts across a behavioral weight loss interventionP20GM144269 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John P Thyfault, STEVEN A WEINMAN · 2022 to 2026
$14.9MMetabolic Phenotyping ClusterS10OD028598 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI THYFAULT, JOHN P · 2020 to 2020
$602kHHS | NIH | National Cancer Institute (NCI) P30CA168524HHS | NIH | National Institute of General Medical Sciences (NIGMS) P20GM144269HHS | NIH | National Institute of General Medical Sciences (NIGMS) R24GM137786HHS | NIH | NIH Office of the Director (OD) S10OD028598NCI NIH HHS P30 CA168524NIGMS NIH HHS P20 GM144269NIGMS NIH HHS R24 GM137786NIH HHS S10 OD028598
6 · The paper itselfAbstract
Indexed as
BRCA1 ProteinEnergy MetabolismMuscle, SkeletalAnimalsFemaleGlucose Tolerance TestHumansMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicBRCA1 ProteinBRCABRCA1/Brca1humanized mousemetabolismproteomics
Identifiers
PMID40353614
PMCPMC12167638
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390